Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.

Huntington's disease is a neurodegenerative disorder characterised primarily by motor abnormalities, and is caused by an expanded polyglutamine repeat in the huntingtin protein. Huntingtin dynamically shuttles between subcellular compartments, and the mutant huntingtin protein is mislocalised t...

Full description

Saved in:
Bibliographic Details
Main Authors: Kathryn R Bowles, Simon P Brooks, Stephen B Dunnett, Lesley Jones
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0144864
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850125244201697280
author Kathryn R Bowles
Simon P Brooks
Stephen B Dunnett
Lesley Jones
author_facet Kathryn R Bowles
Simon P Brooks
Stephen B Dunnett
Lesley Jones
author_sort Kathryn R Bowles
collection DOAJ
description Huntington's disease is a neurodegenerative disorder characterised primarily by motor abnormalities, and is caused by an expanded polyglutamine repeat in the huntingtin protein. Huntingtin dynamically shuttles between subcellular compartments, and the mutant huntingtin protein is mislocalised to cell nuclei, where it may interfere with nuclear functions, such as transcription. However, the mechanism by which mislocalisation of mutant huntingtin occurs is currently unknown. An immortalised embryonic striatal cell model of HD (StHdhQ111) was stimulated with epidermal growth factor in order to determine whether the subcellular localisation of huntingtin is dependent on kinase signalling pathway activation. Aberrant phosphorylation of AKT and MEK signalling pathways was identified in cells carrying mutant huntingtin. Activity within these pathways was found to contribute to the regulation of huntingtin and mutant huntingtin localisation, as well as to the expression of immediate-early genes. We propose that altered kinase signalling is a phenotype of Huntington's disease that occurs prior to cell death; specifically, that altered kinase signalling may influence huntingtin localisation, which in turn may impact upon nuclear processes such as transcriptional regulation. Aiming to restore the balance of activity between kinase signalling networks may therefore prove to be an effective approach to delaying Huntington's disease symptom development and progression.
format Article
id doaj-art-ef3d2d24f256400bbd90ad32587a18a0
institution OA Journals
issn 1932-6203
language English
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-ef3d2d24f256400bbd90ad32587a18a02025-08-20T02:34:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014486410.1371/journal.pone.0144864Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.Kathryn R BowlesSimon P BrooksStephen B DunnettLesley JonesHuntington's disease is a neurodegenerative disorder characterised primarily by motor abnormalities, and is caused by an expanded polyglutamine repeat in the huntingtin protein. Huntingtin dynamically shuttles between subcellular compartments, and the mutant huntingtin protein is mislocalised to cell nuclei, where it may interfere with nuclear functions, such as transcription. However, the mechanism by which mislocalisation of mutant huntingtin occurs is currently unknown. An immortalised embryonic striatal cell model of HD (StHdhQ111) was stimulated with epidermal growth factor in order to determine whether the subcellular localisation of huntingtin is dependent on kinase signalling pathway activation. Aberrant phosphorylation of AKT and MEK signalling pathways was identified in cells carrying mutant huntingtin. Activity within these pathways was found to contribute to the regulation of huntingtin and mutant huntingtin localisation, as well as to the expression of immediate-early genes. We propose that altered kinase signalling is a phenotype of Huntington's disease that occurs prior to cell death; specifically, that altered kinase signalling may influence huntingtin localisation, which in turn may impact upon nuclear processes such as transcriptional regulation. Aiming to restore the balance of activity between kinase signalling networks may therefore prove to be an effective approach to delaying Huntington's disease symptom development and progression.https://doi.org/10.1371/journal.pone.0144864
spellingShingle Kathryn R Bowles
Simon P Brooks
Stephen B Dunnett
Lesley Jones
Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.
PLoS ONE
title Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.
title_full Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.
title_fullStr Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.
title_full_unstemmed Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.
title_short Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.
title_sort huntingtin subcellular localisation is regulated by kinase signalling activity in the sthdhq111 model of hd
url https://doi.org/10.1371/journal.pone.0144864
work_keys_str_mv AT kathrynrbowles huntingtinsubcellularlocalisationisregulatedbykinasesignallingactivityinthesthdhq111modelofhd
AT simonpbrooks huntingtinsubcellularlocalisationisregulatedbykinasesignallingactivityinthesthdhq111modelofhd
AT stephenbdunnett huntingtinsubcellularlocalisationisregulatedbykinasesignallingactivityinthesthdhq111modelofhd
AT lesleyjones huntingtinsubcellularlocalisationisregulatedbykinasesignallingactivityinthesthdhq111modelofhd